Scientists test drug interaction in small safety study
NCT ID NCT06028464
Summary
This early-stage study aimed to understand how taking carbamazepine, a common medication, affects how the body processes a single dose of an experimental drug called BI 1810631. It involved 16 healthy male volunteers who took both drugs in a specific sequence. The goal was to gather basic safety and interaction data to inform future research, not to treat any disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CRS Clinical Research Services Mannheim GmbH
Mannheim, 68167, Germany
Conditions
Explore the condition pages connected to this study.